These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12409365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
    Esteban A, Abarca ML, Cabañes FJ.
    Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
    [Abstract] [Full Text] [Related]

  • 4. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ, Giusiano G, Cárdenes D, Hernández-Molina JM, Eraso E, Quindós G, Guardia C, del Valle O, Tur-Tur C, Guarro J.
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC.
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK, Kohli Y, Batra R.
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests.
    Niewerth M, Splanemann V, Korting HC, Ring J, Abeck D.
    Chemotherapy; 1998 Mar; 44(1):31-5. PubMed ID: 9444406
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G, Tunçoğlu E, Yenişehirli A, Bulut Y.
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique.
    Butty P, Lebecq JC, Mallié M, Bastide JM.
    J Med Vet Mycol; 1995 Dec; 33(6):403-9. PubMed ID: 8683409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC.
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [Abstract] [Full Text] [Related]

  • 20. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.
    Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rinaldi MG, Lee-Yang W, Warnock DW.
    J Clin Microbiol; 2004 Jul; 42(7):2977-9. PubMed ID: 15243047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.